Etomidate Injection
Product Images NDC 0143-9507

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 0143-9507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Etomidate Injection 1)

Chemical structure of Etomidate showing its molecular arrangement with nitrogen-containing heterocyclic and aromatic rings, a methyl group, and an ester functional group.*

FDA Label Image

Ndc 0143-9506-01 Etomidate Injection, Usp 20 mg/10 mL (2 mg/ml) For Intravenous Use Rx Only 10 mL Single Dose Vial Each mL Contains Etomidate 2 mg; Propylene Glycol 35% V/v. Sterile, Nonpyrogenic. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Etomidate Injection 2)

Etomidate Injection, USP 2 mg/mL (20 mg per 10 mL) single dose vial label by Hikma Pharmaceuticals USA Inc. The label states the product is for intravenous use, sterile, and nonpyrogenic, with each mL containing 2 mg etomidate and 35% propylene glycol. It includes storage instructions and manufacturer details from Hikma Farmaceutica (Portugal) and distributor information in Berkeley Heights, NJ.*

FDA Label Image

Plb944-wes/2 (Etomidate Injection 3)

Etomidate Injection, USP 2 mg/mL intravenous injection label from Hikma Pharmaceuticals USA Inc. The label states the total amount as 20 mg per 10 mL in single-dose vials, with 10 vials per package. It includes storage instructions (20° to 25°C), sterile and nonpyrogenic status, and notes the presence of 35% propylene glycol.*

FDA Label Image

Ndc 0143-9507-01 Etomidate Injection, Usp 40 mg/20 mL (2 mg/ml) For Intravenous Use Rx Only 20 mL Single Dose Vial Each mL Contains Etomidate 2 mg; Propylene Glycol 35% V/v. Sterile, Nonpyrogenic. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Etomidate Injection 4)

Etomidate Injection, USP 40 mg per 20 mL (2 mg/mL) label for intravenous use, 20 mL single dose vial by Hikma Pharmaceuticals USA Inc. The label includes storage instructions and active ingredient concentration, listing etomidate 2 mg per mL with propylene glycol 35% v/v, sterile and nonpyrogenic.*

FDA Label Image

Plb945-wes/2 (Etomidate Injection 5)

Label for Etomidate Injection, USP 2 mg/mL, an intravenous injection by Hikma Pharmaceuticals USA Inc. The label indicates 40 mg per 20 mL (2 mg/mL) in single-dose vials, with propylene glycol 35% w/v, sterile and nonpyrogenic. It includes storage instructions and manufacturer details.*

FDA Label Image

Etomidate Injection 6

Label for Etomidate 2 mg/mL injection by Hikma Pharmaceuticals USA Inc. showing a QR code and typical serialization information including GTIN, serial number, expiration date, and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.